InsidersTradesSigma
基于 7 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Wu Yifang, 管理人员. Officer active across 1 company, notably Everest Medicines Ltd.. In total, 9 reports have been published. History available since 27 March 2026. The latest transaction was filed on 11 September 2026 (Purchase). Regulator: HKEX. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Wu Yifang is Dirigeant and Director at Everest Medicines Ltd. The 7 filings on record are purchases, and in the recent sample of 7 filings, purchases total EUR 5783733, with no sales, between 2026-03-31 and 2026-06-05.